ArticleInternational journal of clinical practice2021

Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder.

Azmi Nasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.